help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silverberg, K. M.
Right arrow Articles by Schenken, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silverberg, K. M.
Right arrow Articles by Schenken, R. S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHORIONIC GONADOTROPIN
*ESTRADIOL
*LEUPROLIDE
*PROGESTERONE

Journal of Clinical Endocrinology & Metabolism, Vol 73, 797-803, Copyright © 1991 by Endocrine Society


ARTICLES

Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins

KM Silverberg, WN Burns, DL Olive, RM Riehl and RS Schenken
Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio 78284-7836.

Serum progesterone (P4) levels greater than 2.86 nmol/L (0.9 ng/mL) on the day of hCG administration are reportedly associated with decreased pregnancy rates in in vitro fertilization/embryo transfer (IVF/ET) cycles. To further assess this phenomenon we measured serial serum P4, LH, and estradiol levels in 115 consecutive patients undergoing stimulation for IVF/ET with midluteal leuprolide acetate and human menopausal gonadotropins. IVF/ET cycle outcome was retrospectively correlated with P4 levels on the day of hCG administration. Two critical breakpoints were identified, 1.27 nmol/L (0.4 ng/mL) and 286 nmol/L (0.9 ng/mL). Clinical pregnancies occurred in 9 of 18 patients in group I (P4, less than 1.27 nmol/L) compared to 11 of 81 patients in group II (1.27 less than P4 less than 2.86 nmol/L; P = 0.001) and 0 of 14 patients in group III (P4, less than or equal to 2.86 nmol/L) (P = 0.001). Eleven patients in group III had cryopreservation of embryos during that cycle. Six subsequently underwent frozen embryo transfer, and clinical pregnancies occurred in 2, both of whom have delivered. These findings demonstrate that even modest increases in serum P4 levels (greater than 1.27 nmol/L) are associated with reduced pregnancy rates in IVF/ET cycles. In addition, it appears that the mechanism may not exclusively involve poor oocyte quality.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
C.A. Venetis, E.M. Kolibianakis, E. Papanikolaou, J. Bontis, P. Devroey, and B.C. Tarlatzis
Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis
Hum. Reprod. Update, July 1, 2007; 13(4): 343 - 355.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.A.B. Melo, M. Meseguer, N. Garrido, E. Bosch, A. Pellicer, and J. Remohi
The significance of premature luteinization in an oocyte-donation programme
Hum. Reprod., June 1, 2006; 21(6): 1503 - 1507.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Filicori, G.E. Cognigni, P. Pocognoli, C. Tabarelli, D. Spettoli, S. Taraborrelli, and W. Ciampaglia
Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration
Hum. Reprod., August 1, 2002; 17(8): 2009 - 2015.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Martinez, P.N. Barri, B. Coroleu, R. Tur, T. Sorsa-Leslie, W. J. Harris, N. P. Groome, P. G. Knight, and P. A. Fowler
Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles
Hum. Reprod., March 1, 2002; 17(3): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F.P. Hohmann, J.S.E. Laven, F.H. de Jong, M.J.C. Eijkemans, and B.C.J.M. Fauser
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development
Hum. Reprod., May 1, 2001; 16(5): 846 - 854.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C. A. Krusche, A. Herrler, I. Classen-Linke, C. Hegele-Hartung, U. von Rango, and H. M. Beier
Modulation of endometrial transformation in gonadotrophin-stimulated and unstimulated pseudo-pregnant rabbits: studies with the progesterone receptor antagonist, onapristone
Mol. Hum. Reprod., August 1, 2000; 6(8): 726 - 734.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Yamada, H. Fujiwara, T. Honda, T. Higuchi, T. Nakayama, T. Inoue, M. Maeda, and S. Fujii
Human granulosa cells express integrin {alpha}2 and collagen type IV: possible involvement of collagen type IV in granulosa cell luteinization
Mol. Hum. Reprod., July 1, 1999; 5(7): 607 - 617.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. Doldi, E. Marsiglio, A. Destefani, A. Gessi, G. Merati, and A. Ferrari
Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome
Hum. Reprod., March 1, 1999; 14(3): 601 - 605.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Levesque, M. Letellier, P. W. Dillon, and A. Grant
Analytical performance of Bayer Immuno 1TM estradiol and progesterone assays
Clin. Chem., September 1, 1997; 43(9): 1601 - 1609.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Fujiwara, T. Honda, M. Ueda, K. Nakamura, S. Yamada, M. Maeda, and T. Mori
Laminin Suppresses Progesterone Production by Human Luteinizing Granulosa Cells via Interaction with Integrin {alpha}6{beta}1
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2122 - 2128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society